Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial
Titel:
Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial
Auteur:
Atreya, Raja Peyrin-Biroulet, Laurent Klymenko, Andrii Augustyn, Monica Bakulin, Igor Slankamenac, Dusan Miheller, Pal Gasbarrini, Antonio Hébuterne, Xavier Arnesson, Karin Knittel, Thomas Kowalski, Jan Neurath, Markus F Sandborn, William J Reinisch, Walter